Hudson Bay Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-16,747
Closed -$778K 1051
2023
Q2
$778K Buy
+16,747
New +$579K 0.01% 613

Hudson Bay Capital Management's DICE Position: Q3 2023 in Review

Hudson Bay Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 16,747 shares — an estimated $778K sold.

Hudson Bay Capital Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $778K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Hudson Bay Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 16,747 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $778K.
  • Hudson Bay Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Hudson Bay Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $778K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Hudson Bay Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.